Clinicn Investigator, Assc Prf Urology, Mass General Research Institute

Associate Professor of Surgery Harvard Medical School

Assistant In Urology Massachusetts General Hospital

MPH 2009

MD University of Massachusetts Medical School 2000

biomarkers in prostate cancer; carcinoma transitional cell; congresses as topic; cystatin b; cystectomy; fusion biopsy; genitourinary cancer biomarkers; hemangiopericytoma; leiomyosarcoma; nanoparticles; penile neoplasms; penis; renal cell carcinoma; renal mass biopsy; urinary bladder neoplasms; urogenital neoplasms; urology Dr. Feldman is active in clinical and translational research in renal cell carcinoma, prostate cancer and bladder cancer. In RCC, he is interested in the clinical management and outcomes of the treatment of small renal masses. In prostate cancer, he is interested in biomarker discovery and evaluation and the appropriateness and utility of active surveillance for low risk disease.